摘要
目的:探讨小儿肺炎继发性腹泻行枯草杆菌二联活菌颗粒和蒙脱石散联合治疗分析。方法:200例小儿肺炎继发性腹泻患者均来自于新乡同盟医院2015年2月至2018年2月就诊治疗的患者,将符合要求的患者随机分为两组,观察组患者实施枯草杆菌二联活菌颗粒和蒙脱石散联合治疗.对照组患者实施枯蒙脱石散治疗,比较两组不同治疗方式下患者的退热时间、呕吐改善时间、腹泻改善时间、住院时长以及临床治疗总有效率。结果:观察组患者的退热时间(4.75±1.56)d、呕吐改善时间(4.82±0.25)d、腹泻改善时间(5.02±1.43)d、住院时长(14.27±2.25)d,对照组患者退热时间(2.05±0.13)d、呕吐改善时间(1.96±1.23)d、腹泻改善时间(3.13±0.14)d、住院时长(8.63±2.45)d,观察组患者的临床治疗总有效率(99%),对照组患者的临床治疗总有效率(88%),通过对比患者的临床治疗效果与临床治疗有效率,疗效显著优于对照组患者,(P<0.05)差异具有统计学意义。结论:本研究接受治疗的小儿肺炎继发性腹泻患者,在其接受蒙脱石散治疗的同时,给予其枯草杆菌二联活菌颗粒联合治疗,能有效的改善患者的临床症状,促进退热、呕吐、腹泻等症状的好转.降低患者的住院治疗的时长,提升临床治疗效果,具有临床治疗意义与应用价值。
Objective:To investigate the combined treatment of Bacillus subtilis with montmorillonite powder for secondary diarrhea in children with pneumonia.Methods:200 cases of children with pneumonia secondary diarrhea were treated from February 2015 to February 2018.The patients who met the requirements were randomly divided into two groups.The patients in the observation group were treated with Bacillus subtilis combined with montmorillonite powder,and the patients in the control group were treated with bimontmorillonite powder.The time of antipyretic,vomiting,diarrhea,and length of stay in hospital and total effective rate of clinical treatment were compared between the two groups.Results:The antipyretic time in the observation group was(4.75±1.56)days;the time of improving vomiting was(4.82±0.25)days;the time of improving diarrhea was(5.02±1.43)days;the time of hospitalization was(14.27±2.25)days;the time of antipyretic fever in control group was(2.05±0.13)minutes;the time of improving vomiting was(1.96±1.23)days;the time of improving diarrhea was(3.13±0.14)days;and the time of hospitalization was(8.63±2.45)days.The total effective rate of clinical treatment in the control group was 88%.The effect of bed therapy was significantly better than that of control group(P<0.05).Conclusion:The patients with secondary diarrhea due to pneumonia in our hospital are treated with montmorillonite powder combined with Bacillus subtilis viable bacteria granules,which can effectively improve the clinical symptoms of the patients,and promote antipyretic and vomiting.The improvement of diarrhea and other symptoms can reduce the duration of hospitalization and improve the effect of clinical treatment,which has clinical significance and application value.
作者
张德恩
ZHANG De-en(Xinxiang Alliance Hospital Department of Pediatrics,Xinxiang Henan 453800,China)
出处
《药品评价》
CAS
2018年第15期43-45,共3页
Drug Evaluation
关键词
小儿肺炎
继发性腹泻
枯草杆菌二联活菌颗粒
蒙脱石散
联合治疗
Pediatric Pneumonia
Secondary Diarrhea
Bacillus Subtilis Combined Viable bacteria granules
Montmorillonite Powder
Combined Treatment
